- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Auna S.A.(AUNA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for AUNA
09/25/2026: AUNA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Auna S.A. is a Latin American provider of high-complexity healthcare, operating a dual model of hospitals and health plans. The company's primary strength lies in its integrated payer-provider approach, particularly within specialized segments like oncology. Its main growth story centers on regional expansion across Peru, Colombia, and Mexico. However, investors face risks from high leverage required to fund this expansion, currency volatility, and regional regulatory pressures. The stock may suit growth-oriented investors looking for exposure to emerging market healthcare, but they should monitor debt management and the successful integration of recent acquisitions to determine long-term sustainability.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company is in an active expansion phase across Latin American healthcare markets. |
| Momentum investor | Mixed fit | Momentum depends on positive price trends following recent earnings and growth execution. |
| Value investor | Weak fit | The stock is currently priced for future growth rather than based on current earnings yield. |
| Dividend investor | Weak fit | Auna does not pay a dividend, focusing all capital on reinvestment. |
| Low-risk investor | Weak fit | High leverage and exposure to emerging market economic conditions create higher risk profiles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is subject to sentiment shifts regarding emerging markets and healthcare sector performance. |
| Valuation risk | Medium / high | Investors are paying for future growth that must be executed in complex regulatory environments. |
| Competition risk (regional hospital groups) | Medium | Local competitors and potential new entrants could pressure margins in key markets. |
| Business quality | Medium | The integrated model is robust but capital-intensive and requires high execution capability. |
| Dividend income | Low / none | The firm is currently a non-dividend payer. |
| Execution risk | Medium / high | Successful growth depends on integrating complex new acquisitions and managing large facilities. |
Price Behavior

Flat / Range-Bound
The stock price has been trading within a narrow range with minimal directional movement.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -45.18% | Avg. Invested days 25 | Today’s Advisory WEAK BUY |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 377.69M USD | Price to earnings Ratio 85 | 1Y Target Price 6.99 |
Price to earnings Ratio 85 | 1Y Target Price 6.99 | ||
Volume (30-day avg) 163.3K shares | Beta 0.62 | 52 Weeks Range 4.09 - 6.85 | Updated Date 09/25/2026 |
52 Weeks Range 4.09 - 6.85 | Updated Date 09/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.06 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Healthcare Services | Revenue from inpatient and outpatient hospital stays, oncology treatments, and diagnostic services. | This is the core of their business, generated by patients using their hospital and clinic facilities. |
| Health Plans | Subscription fees from health insurance plans and medical membership programs. | This provides recurring, predictable revenue from members accessing the Auna network. |
| Geography (Latin America) | Operations in Peru, Colombia, and Mexico. | The company relies on economic and healthcare demand growth in these specific Latin American nations. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 85 | Forward PE - | Enterprise Value 1.31B | Price to Sales(TTM) 0.08 |
Enterprise Value 1.31B | Price to Sales(TTM) 0.08 | ||
Enterprise Value to Revenue 0.98 | Enterprise Value to EBITDA 6.2 | Shares Outstanding 30.14M | Shares Floating 27.44M |
Shares Outstanding 30.14M | Shares Floating 27.44M | ||
Percent Insiders 2.82 | Percent Institutions 80.13 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Auna S.A.
Exchange NYSE | Headquarters - | ||
IPO Launch date 2024-03-22 | President, CEO & Executive Chairman of the Board Mr. Jesús Antonio Zamora Leon | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 14796 | Website https://www.aunainvestors.com |
Full time employees 14796 | Website https://www.aunainvestors.com | ||
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare; dental and vision insurance; and oncology plans. It also sells medicines. Auna S.A. was founded in 1989 and is based in Luxembourg, Luxembourg.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

